Baqsimi
NDC Package 0002-6145-27

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Baqsimi is a medication the same as your body's own glucagon, a natural substance that raises blood sugar by causing the body to release sugar stored in the liver. Marketed by Eli Lilly And Company, this product is identified by NDC 0002-6145 and is authorized under FDA application NDA210134.

Identification & Billing

NDC Package Code
0002-6145-27
Package Description
2 TUBE in 1 CARTON / 1 BOTTLE, UNIT-DOSE in 1 TUBE (0002-6145-02) / 1 POWDER in 1 BOTTLE, UNIT-DOSE (0002-6145-01)
Product Code
0002-6145
11-Digit Billing Format
00002614527
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
2 EA

Clinical Specifications

Proprietary Name
Baqsimi
Dosage Form
-
Usage Information
This medication is the same as your body's own glucagon, a natural substance that raises blood sugar by causing the body to release sugar stored in the liver. It is used to treat very low blood sugar (hypoglycemia) that may cause you to need help from others. Make sure a family member or caregiver knows where you keep this medication and how to use it before you need their help.

Regulatory & Marketing

Labeler Name
Eli Lilly And Company
FDA Application #
NDA210134
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-24-2019
End Marketing Date
08-23-2025
Listing Expiration
08-23-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0002-6145). Click a package code to view its specific billing and regulatory data.

0002-6145-11
1 TUBE in 1 CARTON / 1 BOTTLE, UNIT-DOSE in 1 TUBE (0002-6145-02) / 1 POWDER in 1 BOTTLE, UNIT-DOSE (0002-6145-01)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0002-6145-27 identifies a specific commercial package of 2 tube in 1 carton / 1 bottle, unit-dose in 1 tube (0002-6145-02) / 1 powder in 1 bottle, unit-dose (0002-6145-01) of Baqsimi, labeled by Eli Lilly And Company. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Eli Lilly And Company on July 24, 2019. The current certification is valid through August 23, 2025.

What are the primary indications for this medication?

This medication is the same as your body's own glucagon, a natural substance that raises blood sugar by causing the body to release sugar stored in the liver. It is used to treat very low blood sugar (hypoglycemia) that may cause you to need help from others. Make sure a family member or caregiver knows where you keep this medication and how to use it before you need their help.

How is this Eli Lilly And Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00002614527. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 2 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0002-6145-27
11-Digit CMS (5-4-2)
00002-6145-27

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.